Peptic Ulcer Disease
📧 Sign up to get email alerts when something new happens for Peptic Ulcer Disease.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2024-06-12FDA Approved: LANSOPRAZOLE, AMOXICILLIN, CLARITHROMYCIN — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for the fixed-dose combination of lansoprazole, amoxicillin, and clarithromycin from Rising Pharma H…
-
FDA approval · 2024-06-11FDA Approved: LANSOPRAZOLE, AMOXICILLIN, CLARITHROMYCIN — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for a generic fixed-dose combination of lansoprazole, amoxicillin, and clarithromycin. The product i…
-
CLINICAL_TRIALS trial_result · 2024-05-21Clinical Trial Update: Clinical Profile and Outcome of Perforated PUD
A completed clinical trial assessing the clinical profile and outcomes of perforated peptic ulcer disease.
-
CLINICAL_TRIALS trial_result · 2024-04-30Clinical Trial Update: Anticoagulation With Enhanced Gastrointestinal Safety [NA]
A completed clinical trial evaluating anticoagulation with enhanced gastrointestinal safety, focusing on patients with upper gastrointestina…
-
FDA approval · 2024-04-23FDA Approved: PANTOPRAZOLE SODIUM — Supplemental Application (Ajanta Pharma USA Inc.)
FDA approved a supplemental application for pantoprazole sodium (generic pantoprazole) from Ajanta Pharma USA Inc. under ANDA217416.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2024-04-15FDA Approved: PANTOPRAZOLE SODIUM I.V. — Supplemental Application (Piramal Critical Care)
The FDA approved a supplemental application for Pantoprazole Sodium for Injection (IV), submitted by Piramal Critical Care, enabling its con…
-
FDA approval · 2024-03-21FDA Approved: SUCRALFATE — Original Application (Ingenus Pharmaceuticals, LLC)
FDA approved Ingenus Pharmaceuticals' original application for sucralfate (generic formulation).
-
FDA approval · 2024-02-05FDA Approved: ESOMEPRAZOLE MAGNESIUM — Supplemental Application (Zydus Pharmaceuticals USA Inc.)
FDA approved a supplemental application for Esomeprazole Magnesium submitted by Zydus Pharmaceuticals USA Inc., enabling the generic esomepr…
-
FDA approval · 2024-02-01FDA Approved: METHSCOPOLAMINE BROMIDE — Original Application (i3 Pharmaceuticals, LLC)
FDA approved the original application for methscopolamine bromide, a generic anticholinergic agent, filed by i3 Pharmaceuticals, LLC.
-
FDA approval · 2024-01-10FDA Approved: ESOMEPRAZOLE MAGNESIUM — Supplemental Application (Biocon Pharma Inc.,)
The FDA approved Biocon Pharma Inc.'s supplemental application for Esomeprazole Magnesium, a generic esomeprazole product, under ANDA 213486…
-
FDA approval · 2023-12-27FDA Approved: ESOMEPRAZOLE MAGNESIUM — Original Application (Zhejiang Yongtai Pharmaceutical Co., Ltd)
FDA approved Esomeprazole Magnesium from Zhejiang Yongtai Pharmaceutical Co., Ltd under an Original Application (ANDA217022).
-
FDA approval · 2023-12-26FDA Approved: OMEPRAZOLE AND SODIUM BICARBONATE — Supplemental Application (Ajanta Pharma USA Inc.)
FDA approves a supplemental application for a generic omeprazole and sodium bicarbonate product from Ajanta Pharma USA Inc.
-
FDA approval · 2023-12-22FDA Approved: FAMOTIDINE — Original Application (Rising Pharma Holdings, Inc.)
FDA approved Rising Pharma Holdings, Inc.'s original ANDA for famotidine, allowing the generic version to enter the market. Famotidine is an…
-
FDA approval · 2023-11-20FDA Approved: ESOMEPRAZOLE MAGNESIUM — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for Esomeprazole Magnesium from Aurobindo Pharma Limited, indicating regulatory approval of an a…
-
FDA approval · 2023-11-15FDA Approved: ESOMEPRAZOLE MAGNESIUM — Supplemental Application (Sun Pharmaceutical Industries, Inc)
FDA approved a supplemental application for esomeprazole magnesium from Sun Pharmaceutical Industries, Inc. under an ANDA process, indicatin…
-
FDA approval · 2023-10-18FDA Approved: ESOMEPRAZOLE MAGNESIUM — Original Application (Granules Pharmaceuticals Inc.)
FDA approved Granules Pharmaceuticals' original application for esomeprazole magnesium, a proton pump inhibitor, as a generic drug. It is in…
-
FDA approval · 2023-10-11FDA Approved: OMEPRAZOLE — Supplemental Application (Sandoz Inc)
FDA approved a Supplemental Application for omeprazole by Sandoz Inc, confirming approval of a supplement to the Abbreviated New Drug Applic…
-
FDA approval · 2023-09-29FDA Approved: ESOMEPRAZOLE MAGNESIUM DELAYED-RELEASE CAPSULES, 20 MG — Original Application (MARKSANS PHARMA LIMITED)
FDA approved Marksans Pharma Limited's esomeprazole magnesium delayed-release capsules, 20 mg, as a generic therapeutic option for common ac…
-
FDA approval · 2023-09-27FDA Approved: PANTOPRAZOLE — Supplemental Application (NorthStar RxLLC)
FDA approved a supplemental application for pantoprazole by NorthStar RxLLC under ANDA077619.
-
FDA approval · 2023-09-26FDA Approved: PANTOPRAZOLE SODIUM — Supplemental Application (NorthStar Rx LLC)
FDA approved a supplemental application for Pantoprazole sodium from NorthStar Rx LLC.
-
FDA approval · 2023-09-11FDA Approved: ESOMEPRAZOLE MAGNESIUM — Supplemental Application (Cipla USA Inc.)
FDA approved a supplemental application for esomeprazole magnesium submitted by Cipla USA Inc.
-
FDA approval · 2023-08-17FDA Approved: FAMOTIDINE — Original Application (Camber Pharmaceuticals, Inc.)
FDA approves Camber Pharmaceuticals' original application for famotidine, a generic H2 blocker used to treat ulcers and gastroesophageal ref…
-
FDA approval · 2023-08-16FDA Approved: LANSOPRAZOLE, AMOXICILLIN, CLARITHROMYCIN — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for a combination tablet containing lansoprazole, amoxicillin, and clarithromycin (Rising Pharma Hol…
-
FDA approval · 2023-08-16FDA Approved: CLARITHROMYCIN — Supplemental Application (Lannett Company, Inc.)
FDA approved a supplemental application for a generic version of clarithromycin produced by Lannett Company, Inc.
-
FDA approval · 2023-07-18FDA Approved: LANSOPRAZOLE, AMOXICILLIN, CLARITHROMYCIN — Supplemental Application (Rising Pharma Holdings, Inc.)
The FDA granted supplemental approval for a lansoprazole-amoxicillin-clarithromycin combination product by Rising Pharma Holdings, Inc. to e…